Physical therapy in the prevention of musculoskeletal sequelae in patients undergoing chronic psychotropic drug use: A literature review
DOI:
https://doi.org/10.62827/fb.v26i6.1128Keywords:
Psychotropic Drugs; Physical Therapy Modalities; Physical Therapy Services; Functional Medicine.Abstract
Introduction: Chronic use of psychotropic drugs is associated with significant musculoskeletal repercussions, including reduced strength, postural changes, loss of bone density, increased risk of falls, and functional impairment. These changes result from the interaction between pharmacological effects, biopsychosocial factors, and secondary sedentary lifestyle, requiring an interdisciplinary approach that integrates physical therapy, medicine, and educational strategies to prevent and minimize sequelae. Objective: We analyzed the impact of the integration of physical therapy and medicine in the prevention and management of musculoskeletal sequelae in patients undergoing prolonged use of psychotropic drugs, identifying effective rehabilitation strategies, functional protocols, and collaborative care mechanisms. Methods: This is a descriptive and analytical literature review based on national and international publications obtained from the Virtual Health Library (VHL), Latin American and Caribbean Health Sciences Literature (LILACS), PubMed, and Scopus databases. Eleven studies published between 2016 and 2025 were included, selected for their relevance to the musculoskeletal effects of psychotropic drugs, risk of falls, bone loss, motor changes, and interdisciplinary approaches aimed at preventing these outcomes. Results: Evidence suggests that structured programs involving resistance exercises, balance training, lower limb strengthening, motor reeducation, and health education significantly reduce the functional impact of psychotropic drugs. Interventions associated with medical follow-up, including monitoring of side effects, pharmacological adjustment, and metabolic and bone risk assessment, have been shown to prevent falls, minimize bone mineral density loss, and improve mobility. Multidisciplinary models, educational support, and continuity of care strategies, including telerehabilitation, have proven to be decisive for adherence, engagement, and maintenance of results. Conclusion: An interdisciplinary approach between physical therapy and medicine is essential to prevent musculoskeletal sequelae in chronic users of psychotropic drugs. Individualized, evidence-based protocols combining therapeutic exercises, continuous clinical monitoring, and biopsychosocial strategies promote the preservation of functionality, postural stability, and autonomy. This collaborative model reaffirms the importance of professional integration and patient-centered care as essential pillars of contemporary musculoskeletal rehabilitation.
References
O’Donnell D, Briggs R, Aiken FM, Kelly RA, Moriarty F, O’Donovan D, et al. Association between psychotropic medication use and gait and mobility impairment in community-dwelling older people: data from The Irish Longitudinal Study on Ageing (TILDA). J Gerontol A Biol Sci Med Sci [Internet]. 2025 [cited 2025 Dec 03];80(5):glae263. Available from: https://academic.oup.com/biomedgerontology/article/80/5/glae263/7877097. doi:10.1093/gerona/glae263 OUP Academic
Kang S, Han M, Kim EH, Boo YJ, Park CI, Jung I. Use of serotonin reuptake inhibitors and risk of subsequent bone loss: longitudinal cohort study. Sci Rep [Internet]. 2025 [cited 2025 Dec 03]. Available from: https://www.nature.com/articles/s41598-024-80471-6. doi:10.1038/s41598-024-80471-6 Nature
Guo M, Tao S, Xiong Y, Li J, Chen Z, Wang Y, et al. Comparative analysis of psychiatric medications and their association with falls and fractures: a systematic review and network meta-analysis. Psychiatry Res [Internet]. 2024 [cited 2025 Dec 02];338:115974. Available from: https://www.sciencedirect.com/science/article/pii/S0165178124002592. doi:10.1016/j.psychres.2024.115974
Hu J, Smith T, López A, Fernández M, Santos R, Müller P, et al. Osteoporosis and fracture risk associated with novel antidepressants: a systematic review and meta-analysis. Actas Españolas Psiquiatr [Internet]. 2024 [cited 2025 Dec 02];52(3):334-346. Available from: https://actaspsiquiatria.es/index.php/actas/article/view/1560. doi:10.62641/aep.v52i3.1560
Rozing MP, Janssen P, Verhoeven AC, de Jong H, Visser J, Dekker J, et al. Use of hypnotic-sedative medication and risk of falls and fractures in older adults. Acta Psychiatr Scand [Internet]. 2023 [cited 2025 Nov 30]. Available from: https://onlinelibrary.wiley.com/doi/10.1111/acps.13610. doi:10.1111/acps.13610
Mercurio M, Rossi L, Bianchi S, Ferrari G, Conte A, De Luca V, et al. The use of antidepressants is linked to bone loss: a systematic review and meta-analysis. Orthop Rev [Internet]. 2022 [cited 2025 Dec 02];14(1):38564. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568413/. doi:10.4081/or.2022.38564
de Filippis R, Santoro L, Russo F, Esposito A, Romano M, Pirozzi C, et al. Antidepressants and vertebral and hip fracture risk. Healthcare [Internet]. 2022 [cited 2025 Dec 02];10(5):803. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140335/. doi:10.3390/healthcare10050803
Treves N, Liperoti R, Cattel C, Onder G, Cherubini A, Logroscino G, et al. Z-drugs and risk for falls and fractures in older adults: a systematic review and meta-analysis. Age Ageing [Internet]. 2018 [cited 2025 Dec 02];47(2):201-209. Available from: https://academic.oup.com/ageing/article/47/2/201/4564456. doi:10.1093/ageing/afx170
Schweiger JU, Müller H, Hoffmann T, Becker R, Fischer P, Grünwald J, et al. The use of antidepressive agents and bone mineral density in women: a meta-analysis. Int J Environ Res Public Health [Internet]. 2018 [cited 2025 Dec 02];15(7):1373. Available from: https://www.mdpi.com/1660-4601/15/7/1373. doi:10.3390/ijerph15071373
Bolton JM, Robinson J, Sareen J, Bolton E, Crawford A, Patten S, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry [Internet]. 2017 [cited 2025 Dec 02];74(4):387-395. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2618262. doi:10.1001/jamapsychiatry.2017.0077
Boldt AS, Hatton A, Grund S, Schmidt H, Peters K, Meyer E, et al. The impact of psychotropic medications on muscle function, fall risk, and bone density: implications for rehabilitation. Curr Opin Psychiatry [Internet]. 2016 [cited 2025 Dec 01];29(5):380-387. Available from: https://journals.lww.com/copri/fulltext/2016/09000/the_impact_of_psychotropic_medications_on_muscle.4.aspx. doi:10.1097/YCO.0000000000000272
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Marcele Zago Marcolan, Julia Torres Rocha , Anna Flavia Vieira Pinto, Camila Pereira Morbelli , Maria Vitória Guerini Novaes , Isadora Schwartz Meireles , Virginia Modenesi, Júlia Moreno Castro de Oliveira (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution 4.0 que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
Autores têm autorização para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.